TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - STRYKER CORP. Stock

Certificat

DE000SQ39R97

Delayed Deutsche Boerse AG 05:09:46 2024-06-03 EDT
0.91 EUR +2.25% Intraday chart for TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - STRYKER CORP.
1 month-3.26%
3 months-15.24%
Date Price Change
24-06-03 0.91 +2.25%
24-05-31 0.89 -3.26%
24-05-30 0.92 -1.08%
24-05-29 0.93 +3.33%
24-05-28 0.9 +4.65%

Delayed Quote Deutsche Boerse AG

Last update June 03, 2024 at 05:09 am

More quotes

Static data

Product typeCertificat Turbo
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer Société Générale Société Générale
WKN SQ39R9
ISINDE000SQ39R97
Date issued 2022-11-14
Strike 241.4 $
Maturity Unlimited
Parity 100 : 1
Emission price 0.11
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.13
Lowest since issue 0.077
Spread 0.04
Spread %4.21%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
341.1 USD
Average target price
373.1 USD
Spread / Average Target
+9.38%
Consensus